EnteroMedics was incorporated in December 2002.
We were incorporated in Minnesota in December 2002 under the name Beta Medical, Inc. In 2003, we changed our name to EnteroMedics Inc. and in 2004 we reincorporated in Delaware. In October 2017, we changed our name to ReShape Lifesciences, Inc.
Our principal executive offices are located at 1001 Calle Amanecer, San Clemente, CA 92673, and our telephone number is (949) 429-6680.
The Company completed its initial public offering on November 15, 2007.
EnteroMedics trades on NASDAQ under the symbol RSLS.
The Company operates with a December 31 fiscal year end.
Annual Reports, Form 10-Ks, Form 10-Qs and other reports are posted to this website as soon as they are filed with the SEC.
Contact a licensed stockbroker to purchase shares in our company.
The Company is a medical technology company focused on the design, development and communication of transformative technology to treat obesity and metabolic diseases.
The Company has not historically paid dividends.
Wells Fargo Bank National Association
Equiniti (formerly Wells Fargo Shareowner Services)
Deloitte & Touche LLP (Minneapolis, MN)